Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v18-EN | Version v14-FR | |
---|---|---|
Language | English | French |
Date Updated | 2023-01-20 | 2022-06-03 |
Drug Identification Number | 02304341 | 02304341 |
Brand name | SODIUM CHLORIDE INJECTION USP 0.9% | SODIUM CHLORIDE INJECTION USP 0.9% |
Common or Proper name | Sodium Chloride Injection USP | Sodium Chloride Injection USP |
Company Name | HIKMA CANADA LIMITED | HIKMA CANADA LIMITED |
Ingredients | SODIUM CHLORIDE | SODIUM CHLORIDE |
Strength(s) | 9MG | 9MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10 mL | 10 mL |
ATC code | V07AB | V07AB |
ATC description | ALL OTHER NON-THERAPEUTIC PRODUCTS | ALL OTHER NON-THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | ||
Actual start date | 2021-07-20 | 2021-07-20 |
Estimated end date | 2022-08-03 | 2022-07-08 |
Actual end date | 2022-08-03 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | Yes |
Company comments | Inventory released to market in May and June. Product will remain on allocation until resupply. | |
Health Canada comments |